221.65MMarket Cap-1800P/E (TTM)
1.520High1.400Low119.23KVolume1.450Open1.420Pre Close175.18KTurnover0.14%Turnover RatioLossP/E (Static)153.93MShares5.25052wk High1.32P/B125.82MFloat Cap0.50152wk Low--Dividend TTM87.38MShs Float13.780Historical High--Div YieldTTM8.44%Amplitude0.393Historical Low1.469Avg Price1Lot Size
Renovaro Stock Forum
NEWS
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
RenovaroCube acquires 100% ownership of Cyclomics, solidifying their collaboration in cancer diagnostics.
The partnership with Oxford Nanopore and Nvidia enhances RenovaroCube's capabilities in early cancer detection and treatment monitoring.
RenovaroCube's open architecture AI platform combined with Cyclomics' 4th generation molecular technology enables accurate ...
The two companies have agreed to merge, with artificial intelligence medical technology firm GEDi becoming a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
No comment yet